Literature DB >> 25270261

Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.

A Cousien1, V C Tran, S Deuffic-Burban, M Jauffret-Roustide, J-S Dhersin, Y Yazdanpanah.   

Abstract

Equipment sharing among people who inject drugs (PWID) is a key risk factor in infection by hepatitis C virus (HCV). Both the effectiveness and cost-effectiveness of interventions aimed at reducing HCV transmission in this population (such as opioid substitution therapy, needle exchange programmes or improved treatment) are difficult to evaluate using field surveys. Ethical issues and complicated access to the PWID population make it difficult to gather epidemiological data. In this context, mathematical modelling of HCV transmission is a useful alternative for comparing the cost and effectiveness of various interventions. Several models have been developed in the past few years. They are often based on strong hypotheses concerning the population structure. This review presents compartmental and individual-based models to underline their strengths and limits in the context of HCV infection among PWID. The final section discusses the main results of the papers.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  antiviral treatment; dynamic modelling; harm reduction policies; hepatitis C; injecting drug users

Mesh:

Substances:

Year:  2014        PMID: 25270261     DOI: 10.1111/jvh.12337

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  12 in total

1.  Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?

Authors:  Ilias Gountas; Vana Sypsa; Olga Anagnostou; Natasha Martin; Peter Vickerman; Evangelos Kafetzopoulos; Angelos Hatzakis
Journal:  Addiction       Date:  2017-02-17       Impact factor: 6.526

2.  Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies.

Authors:  Hayley Bennett; Jason Gordon; Beverley Jones; Thomas Ward; Samantha Webster; Anupama Kalsekar; Yong Yuan; Michael Brenner; Phil McEwan
Journal:  Eur J Health Econ       Date:  2016-11-01

Review 3.  Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.

Authors:  Ashley B Pitcher; Annick Borquez; Britt Skaathun; Natasha K Martin
Journal:  J Theor Biol       Date:  2018-11-16       Impact factor: 2.691

4.  Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.

Authors:  L Leon; S Kasereka; F Barin; C Larsen; L Weill-Barillet; X Pascal; S Chevaliez; J Pillonel; M Jauffret-Roustide; Y LE Strat
Journal:  Epidemiol Infect       Date:  2016-12-22       Impact factor: 4.434

5.  Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections.

Authors:  Alexander Gutfraind; Basmattee Boodram; Nikhil Prachand; Atesmachew Hailegiorgis; Harel Dahari; Marian E Major
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

6.  Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.

Authors:  Desarae Echevarria; Alexander Gutfraind; Basmattee Boodram; Marian Major; Sara Del Valle; Scott J Cotler; Harel Dahari
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

7.  Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.

Authors:  Aaron G Lim; Huma Qureshi; Hassan Mahmood; Saeed Hamid; Charlotte F Davies; Adam Trickey; Nancy Glass; Quaid Saeed; Hannah Fraser; Josephine G Walker; Christinah Mukandavire; Matthew Hickman; Natasha K Martin; Margaret T May; Francisco Averhoff; Peter Vickerman
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

8.  Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.

Authors:  Rui Fu; Alexander Gutfraind; Margaret L Brandeau
Journal:  Math Biosci       Date:  2016-01-14       Impact factor: 3.935

9.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22

10.  Hepatitis C virus prevention and care for drug injectors: the French approach.

Authors:  Jean-Michel Delile; Victor de Ledinghen; Marie Jauffret-Roustide; Perrine Roux; Brigitte Reiller; Juliette Foucher; Daniel Dhumeaux
Journal:  Hepatol Med Policy       Date:  2018-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.